News & Views
Irish Venture to Deliver Biodegradable Implants
May 24 2013
A consortium of three Irish biomedical companies - Venn Life Sciences Holdings Plc, Cellulac Ltd and Biopharmed West Ltd have announce a joint venture to pursue the development of biodegradable human implants. The joint venture provides a complement of expertise beginning at traceability and processing of raw materials to finished medical grade PolyLactic Acid, (PLA), a component in the manufacture of implanted medical devices in the operating theatre. Product range is potentially from internal sutures to orthopaedic bone regeneration implants providing a clean technological solution for the replacing of titanium.
Venn Life Sciences is to provide clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients. Cellulac Limited, currently involved in a major EU project involving potential uses of biobased chemicals from lignocellulose and alga, will provide the scientific laboratories, production and clean room infrastructure, quality controls and access to its portfolio of patents in the production of biodegradable PLA. Partners in this project include Fraunhofer Institiute, Nova Institute and Wageningen University.
Biopharmed West Limited will contribute institutional, commercial know-how and management of distribution channels
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan